Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3
ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
Slightly above 55% of Zivo Bioscience's sophisticated investors are presently thinking to get in. The analysis of overall sentiment of trading Zivo Bioscience Warrants stock suggests that some investors are interested at this time. Zivo Bioscience's investing sentiment can be driven by a variety of factors including economic data, Zivo Bioscience's earnings reports, geopolitical events, and overall market trends.
Zivo |
Filed transaction by Edwards Lifesciences Corp Officer: Svp, Princ. Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Zivo Bioscience Fundamental Analysis
We analyze Zivo Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Zivo Bioscience is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Zivo Bioscience Warrants Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
Peers
Zivo Bioscience Related Equities
GOVXW | GeoVax Labs | 8.33 | ||||
BCTXW | BriaCell Therapeutics | 8.33 | ||||
LEXXW | Lexaria Bioscience | 9.09 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bonds Directory Find actively traded corporate debentures issued by US companies |